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Abstract
Background: Studying the impact of genetic testing interventions on lifestyle behaviour change has been a priority
area of research in recent years. Substantial heterogeneity
exists in the results and conclusions of this literature, which
has yet to be explained using validated behaviour change
theory and an assessment of the quality of genetic interventions. The theory of planned behaviour (TPB) helps to explain
key contributors to behaviour change. It has been hypothesized that personalization could be added to this theory to
help predict changes in health behaviours. Purpose: This
systematic review provides a detailed, comprehensive identification, assessment, and summary of primary research
articles pertaining to lifestyle behaviour change (nutrition,
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physical activity, sleep, and smoking) resulting from genetic
testing interventions. The present review further aims to
provide in-depth analyses of studies conducted to date
within the context of the TPB and the quality of genetic interventions provided to participants while aiming to determine whether or not genetic testing facilitates changes in
lifestyle habits. This review is timely in light of a recently published “call-to-action” paper, highlighting the need to incorporate the TPB into personalized healthcare behaviour
change research. Methods: Three bibliographic databases,
one key website, and article reference lists were searched for
relevant primary research articles. The PRISMA Flow Diagram
and PRISMA Checklist were used to guide the search strategy
and manuscript preparation. Out of 32,783 titles retrieved,
26 studies met the inclusion criteria. Three quality assessments were conducted and included: (1) risk of bias, (2) quality of genetic interventions, and (3) consideration of theoretical underpinnings – primarily the TPB. Results: Risk of
bias in studies was overall rated to be “fair.” Consideration of
the TPB was “poor,” with no study making reference to this
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validated theory. While some studies (n = 11; 42%) made reference to other behaviour change theories, these theories
were generally mentioned briefly, and were not thoroughly
incorporated into the study design or analyses. The genetic
interventions provided to participants were overall of “poor”
quality. However, a separate analysis of studies using controlled intervention research methods demonstrated the
use of higher-quality genetic interventions (overall rated to
be “fair”). The provision of actionable recommendations informed by genetic testing was more likely to facilitate behaviour change than the provision of genetic information
without actionable lifestyle recommendations. Several studies of good quality demonstrated changes in lifestyle habits
arising from the provision of genetic interventions. The most
promising lifestyle changes were changes in nutrition. Conclusions: It is possible to facilitate behaviour change using
genetic testing as the catalyst. Future research should ensure that high-quality genetic interventions are provided to
participants, and should consider validated theories such as
the TPB in their study design and analyses. Further recommendations for future research are provided.
© 2018 S. Karger AG, Basel

Introduction

Since decoding the entire human genome in 2003 [1],
there have been considerable advances in genetic research
and the clinical utility of genetic testing. The terms nutri
genomics or nutritional genomics describe the study of
how genes interact with the foods, beverages, and supplements consumed to influence health outcomes [2]. Currently, there are no generally accepted or standardized
terms describing the study of how genes interact with
physical activity, sleep, or smoking to influence subsequent health outcomes. These gene-lifestyle interactions
can be referred to using the broad term lifestyle genomics.
Despite the lack of a standardized terminology, research
pertaining to nutrigenomics and other emerging genomic sciences continues to advance. Specifically, behaviour
change guided by genetic testing results or other personalized healthcare information is emerging as a priority
area of research, with several reviews on this topic published in recent years [3–6].
Genetic testing is increasingly used in clinical practice
to provide personalized information and recommendations about health risks and lifestyle habits at a relatively
low cost [7]. However, studies assessing whether or not
genetic testing promotes changes in lifestyle habits have
conflicting findings [8–11]. Given that chronic diseases
50
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can often be managed through lifestyle interventions
alone, or a combination of lifestyle interventions and
medication [12–14], genetic tests providing personalized
lifestyle recommendations hold considerable promise.
Behaviour change is a multifactorial, complex area of
research and clinical practice. The theory of planned behaviour (TPB) is arguably the most widely accepted behaviour change theory in academia [15]. This theory posits that attitudes, subjective norms, and perceived behavioural control are key constructs that can be used to
predict behaviours. Actual behavioural control, which
typically refers to factors such as income, educational level, and other social determinants of health for the purposes of healthcare research, further contributes to one’s
likelihood of performing a behaviour [15, 16]. It is important for genetic testing behaviour change research to consider validated theories in order to control for a number
of confounding factors that could significantly influence
the results of a study.
Despite the complexity of behaviour change, genetic
testing behaviour change studies do not often use any theoretical underpinnings to inform their study design, or
for the analysis and interpretation of their data. This is
concerning, as it implies that these studies did not report
whether they considered the many confounding factors
impacting behaviour change, including but not limited to
attitudes, subjective norms, and perceived and actual behavioural control [17]. Consideration of such factors
could help explain why some studies conclude that genetic testing facilitates health behaviour change, while
others conclude that it does not. For example, a study may
find that genetic testing has a positive influence on attitudes and subjective norms, but it is only when behavioural control is high (for example, with a higher income
or education level) that genetic testing facilitates health
behaviour change. The importance of such considerations has been highlighted in a recent call to action for
personalized healthcare behaviour change research,
which recommended the completion of a systematic review with perspective from the TPB as an important next
step in advancing knowledge in personalized healthcare
behaviour change literature [18].
Systematic reviews and meta-analyses are typically
considered the highest quality of scientific evidence and,
notably, often guide clinical practice [19]. When it comes
to systematic reviews assessing behaviour change as a result of genetic testing interventions, a simple risk-of-bias
assessment is not sufficient to develop the most meaningful conclusions; yet it is often the only quality assessment
conducted in this type of work [3, 5, 6]. It is further imHorne/Madill/O’Connor/Shelley/Gilliland

Fig. 1. Search terms.

nutrigenetic* OR nutrigenomic* OR DNA OR “nutritional genomic*” OR gene OR genes OR
genetic* OR genom* OR “personalized nutrition” OR “personalised nutrition”
AND
behavior* OR behaviour* OR habit* OR smoking OR smoke* OR diet OR nutrition OR “physical
activity” OR exercise OR sleep
AND
change OR changes OR effect OR effects OR impact OR impacts OR modif*
AND
information OR recommendation* OR advice OR intervention OR program* OR counsel*

portant to consider the delivery of a health/genetic intervention (such as considering the provision of disease risk
estimates vs. actionable behaviour change recommendations) and to consider behaviour change theories [18].
Therefore, the development of more comprehensive
methods for reviewing and compiling the primary research articles conducted to date related to genetic testing
behaviour change is needed.
The present review provides an in-depth analysis and
summary of the current body of knowledge, thus presenting the most robust and comprehensive review of genetic
testing behaviour change research conducted to date.
Overall, the purpose of this comprehensive systematic review is to use these novel perspectives to answer the following research questions: Are we considering validated
behaviour change theory (particularly the TPB) in genetic testing behaviour change research? Are we using highquality genetic interventions in genetic testing behaviour
change research? What is the impact of genetic testing on
behaviour change pertaining to four lifestyle factors: nutrition, physical activity, smoking, and/or sleep? These
four lifestyle factors were chosen as they have all been
shown to have a significant impact on chronic disease
management [20–24]. Behaviour change is challenging,
and it is important to find strategies that effectively facilitate beneficial lifestyle changes related to nutrition,
physical activity, smoking, and/or sleep. Genetic tests
may provide information on disease risk, which can be
mitigated through specific alterations in lifestyle habits
such as improving nutrition, optimizing physical activity
habits, quitting smoking or smoking less, and engaging in
healthful sleep-related behaviours.

ticles: PubMed, Scopus, and Nursing & Allied Health. Publications
posted on the Food4Me website [27], as well as the reference lists
of 4 recent review articles published on topics similar to those of
the present review [3–6], were also screened for articles relevant to
the research questions. After the number of records had been condensed through title and abstract screening, the full-text articles
were reviewed to assess each one for eligibility according to pre
determined inclusion and exclusion criteria. The complete search
terms and search strategy were developed and approved by all authors, and they are detailed in Figure 1 and Figure 2, respectively.
Selection Criteria
To capture a comprehensive summary of the research conducted to date, the present review was not limited to a single, specific
study design. We included primary research articles published in
English in peer-reviewed journals from all years which assessed the
impact of genetic testing on one or more of the four lifestyle habits
of interest (nutrition, physical activity, smoking, and/or sleep).
Both qualitative and quantitative studies were included. Studies
were excluded if there was not at least one group of participants
who underwent genetic testing and/or if the study did not provide
follow-up data related to one or more of the lifestyle habits of interest after the participants had received the results of a genetic test.
One author (J.H.) completed data extraction using piloted forms
[28], which were tested on 4 studies, reviewed by another author
(J.G.), and modified during the piloting process by two authors
(J.H. and J.G.).

Search Strategy
The systematic review protocol that was used to guide this review is detailed elsewhere [25]. In brief, the search strategy was
guided by the PRISMA Flow Diagram [26]. From February to
April 2017, the following databases were searched for relevant ar-

Analysis
The National Institutes of Health (NIH) Study Quality Assessment Tools were used to conduct a risk-of-bias assessment in
quantitative research [29]. The Critical Appraisal Skills Programme Qualitative Research Checklist [30] was used to assess risk
of bias in qualitative research. The quality of the genetic intervention was also assessed. To our knowledge, there currently is no tool
available for assessing the quality of a genetic intervention. As
such, we developed the first assessment tool for evaluating the
quality of a genetic intervention provided to subjects (online suppl. Table 1; see www.karger.com/doi/10.1159/000488086 for all
online suppl. material). The quality rating and general outline for
this new tool was based on the format of the NIH Study Quality
Assessment Tools [29]. The questions included were developed
from a review of previously identified critiques and concerns related to genetic testing and health risk messages [11, 31–38].
Consideration of the main components of the TPB (attitudes
towards a behaviour, subjective norms, behavioural control, and
intention) [17], as well as consideration of theory more generally,
was assessed using deductive content analysis of the manuscripts
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Methods

51

Identification

Records screened
(n = 32,783)

Records excluded as they did
not meet predetermined
inclusion/exclusion criteria
(n = 32,713)

Full-text articles assessed for eligibility
(n = 70)

Full-text articles excluded
with reasons (n = 44):

Studies included in qualitative synthesis* (n = 26):

Ineligible outcome: n = 27
Not primary research: n = 10
Ineligible intervention: n = 4
Ongoing study: n = 2
Poster presentation: n = 1

Included

Screening

Records identified through
other sources
(n = 226)

Eligibility

Records identified through
database searches
(n = 32,557)

Nutrition (n = 18)
Physical activity (n = 16)
Sleep (n = 0)
Smoking (n = 12)

Fig. 2. Search strategy guided by the PRISMA Flow Diagram. * Several articles assessed behaviour change related

to >1 lifestyle factor of interest; therefore, the total number of records included in the systematic review does not
match the total number of articles by lifestyle category.

[39]. The deductive content analyses of consideration of the TPB
and its key components in each study was then translated into a
rating, based on the rating system generated in the NIH Study
Quality Assessment Tools, whereby “good” indicates a robust consideration of the main components of the TPB, “fair” indicates
intermediate consideration of the main TPB components, and
“poor” represents little to no consideration of the main TPB components. An overall quality score was assigned to each article based
on a point system, where “good” ratings were awarded 3 points,
“fair” ratings were awarded 2 points, and “poor” ratings were
awarded 1 point. The maximum possible overall quality rating was
9/9, upon consideration of all three assessments.

Results

The comprehensive electronic literature search returned a total of 32,783 results, with 26 studies meeting
the predetermined inclusion criteria. In these 26 studies,
the following outcomes were assessed: nutrition (n = 18),
physical activity (n = 16), and smoking (n = 12) (Fig. 1),
with 14 articles assessing more than one lifestyle habit of
interest to this review. The vast majority of the literature
has been published over the past decade, with a large spike
52
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in publications recently in 2015 (online suppl. Fig. 1).
Consistent with recommendations for systematic reviews
[25], our review was analytic and descriptive in nature
and included: (a) a tabulation of the study characteristics
and findings (Table 1); (b) a thorough and robust quality
assessment (Table 2); and (c) a narrative synthesis. Research conducted thus far has focused on a variety of
genes, as outlined in Table 3. It is concerning to note that
12 studies (46%) did not report whether or not the authors had a conflict of interest (COI). The vast majority
of the literature has focused on genetic testing for determining the risk of developing certain diseases or conditions (88%; n = 23), while only a small number of studies
have focused on nutrient metabolism (12%; n = 3), which
indirectly affects the risk of developing diseases or con
ditions [40–42]. The three separate quality assessments
completed on each study are summarized in Table 2. Risk
of bias was overall rated as “fair.”
Are We Using High-Quality Genetic Interventions?
Although some risk of bias is apparent, the ratings for
the quality of the genetic interventions were more conHorne/Madill/O’Connor/Shelley/Gilliland

Table 1. Summary of study characteristics and behaviour change findings
First author
[Ref.], date

Participants
(n baseline;
n follow-up)

Intervention
group(s)

Comparison
group(s)

Target diseases/
conditions
(genes tested)

Follow-up

Lifestyle habits
assessed

Outcomes (p values);
conclusions

Ranking
of study
design1

COI

Roke [43],
2017

Young female
adults
(n = 57;
n = 56)

Genetic
testing

No genetic
testing

Health effects related
to omega-3 intake
(FADS1)

3 months

Nutrition
(omega-3:
EPA and DHA)

NS change in omega-3
intake in the genetic
testing group compared
to the control group (no
genetic testing)

1

No

Marsaux [10],
2016

Adults
(n = 265;
n = 130)

High-risk
genetic
result

Non-risk
genetic result

Overweight/
obesity (FTO)

6 months

Physical activity

NS change in subjective
or objective physical
activity with provision of
FTO genotype risk info

3

Yes

Meisel [44],
2015

Young adults
(n = 1,016;
n = 279)

Genetic
testing

No genetic
testing

Obesity (FTO)

1 month

Nutrition (adherence to a variety
of eating behaviours) and physical activity

NS changes in nutrition
and physical activity
(pooled) between groups

1

No

Boeldt [45],
2015

Adults working
at health and
technology
companies
(NR; n = 2,037)

Genetic
testing

None

23 conditions including heart attack,
Alzheimer disease,
type 2 diabetes,
obesity, colon cancer,
and cervical cancer
(NR)

5.6±2.4
months

Nutrition
(dietary fat) and
physical activity

NS (significance level
NR) change in nutrition
and physical activity
following genetic testing2

4

No

HieterantaLuoma [9],
2015

Adults
(n = 122;
n = 113 at
12 months)

Genetic
testing

No genetic
testing

Cardiovascular
disease (apoE)

High-risk
genetic
result

Non-risk
genetic result

Improved dietary fat
quality in the high-risk
genetic result group vs.
the control group at 2
weeks (p < 0.05) and 6
months of follow-up (p <
0.05); decreased intake of
high-fat, high-sugar
foods in the non-risk
genetic result group vs.
the control group at 12
months (p < 0.05)

No

and

Nutrition (fat
quality, and
consumption of
vegetables, berries, fruits, and
fatty and sugary
foods) and physical activity

1

and

2 weeks
6 months
12 months

Voils [46],
2015

Veterans
(n = 601;
n = 506 at
3 months,
n = 472 at
6 months)

Genetic
testing

No genetic
testing

Type 2 diabetes
(TCF7L2, PPARγ,
and KCNJ11)

3 months
6 months

Nutrition (calories, carbohydrates, protein,
fat, saturated fat,
MUFA, and
PUFA) and
physical activity

Reduced calories and fat
(MUFA and PUFA) in
the genetic testing group
vs. the no-genetic-testing
group (p < 0.05) at 3
months; NS changes in
nutrition between the
groups at 6 months; NS
changes in physical
activity at either time
point

1

Yes

Marsaux [47],
2015

Adults
(n = 1,607;
n = 1,233 with
subjective data
at 6 months,
n = 730 with objective data at
6 months)

Genetic
testing

No genetic
testing

Overweight/
obesity (FTO)

3 months
6 months

Physical activity

NS changes in physical
activity with the addition
of genetic information

1

Yes

Nielsen [11],
2014

Adults
(n = 138;
n = 130 at
3 months,
n = 123 at
12 months)

High-risk
genetic
result

No genetic
testing

Caffeine metabolism
(CYP1A2), vitamin C
utilization (GSTT1
and GSTM1), sweet
taste perception
(TAS1R2), and
sodium sensitivity
(ACE)

3 months
12 months

Nutrition (caffeine, vitamin C,
added sugar, and
sodium)

The high-risk genetic
result group (for the
ACE gene) had reduced
sodium intake to a
greater extent than the
control group by the
12-month follow-up (p =
0.008); NS changes in
caffeine, vitamin C, and
added sugar intake at
each follow-up time
point; NS changes in
sodium intake at the
3-month follow-up

1

Yes

and
Non-risk
genetic
result

Genetic Testing and Lifestyle Behaviour
Change
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Table 1 (continued)
First author
[Ref.], date

Participants
(n baseline;
n follow-up)

Intervention
group(s)

Comparison
group(s)

Target diseases/
conditions
(genes tested)

Follow-up

Lifestyle habits
assessed

Outcomes (p values);
conclusions

Ranking
of study
design1

COI

Egglestone
[8], 2013

Adults who had
purchased a
DTC genetic
test or were
considering
purchasing a
test or who were
awaiting their
results
(n = 275)

Genetic
testing

No genetic
testing

NR (NR)

Varied

Nutrition (healthier diet, vitamins/
supplements,
caffeine, fibre,
salt, fat, and
fruits/vegetables),
physical activity,
and smoking

Greater health behaviour
scores in the genetic
testing group vs. the
control group (p = 0.02
for pooled nutrition,
physical activity, and
smoking); the most
common changes were
“healthier diet,” “more
exercise,” and “taking
vitamins or supplements”; more often
reported “sufficient fruit
and vegetable intake” in
the genetic testing group
(p = 0.03); NS changes in
smoking individually

2

NR

Bloss [48],
2013

Adults working
at health and
technology
companies
(n = 3,639;
n = 2,037 at
3 months, n =
1,325 at 14±
1.3 months)

Genetic
testing

None

Deep vein thrombosis, melanoma,
sarcoidosis, haemochromatosis, lactose
intolerance, breast
cancer, prostate
cancer + 20 other
conditions not listed
(variable)

3 months
14±1.3
months

Nutrition (dietary
fat) and physical
activity

NS changes in nutrition
or physical activity at
3 months (significance
level NR) or 14±1.3
months

4

No

Kaufman [49],
2012

Adult
customers of
DTC genetic
testing
companies
(n = 3,167;
n = 1,048)

Genetic
testing

Non-risk
genetic result

Variable
(variable)

2–8 months

Nutrition (change
diet) and physical
activity

The participants who
considered themselves at
high risk of colon cancer
were significantly more
likely to change their diet
(p = 0.02) and start
exercising more (p =
0.01) than those who
considered themselves at
low risk of colon cancer;
10% of all participants
reported they changed a
supplement, 33% reported being more careful
about their diet, and 14%
reported exercising more

2

NR

Adults with
1st-degree
relatives with
Crohn disease
(n = 497;
n = 426)

Genetic
testing

No genetic
testing

Crohn disease
(NOD2)

6 months

Smoking

1

No

and

and

High-risk
genetic
result

Non-risk
genetic result

NS changes in smoking
cessation between the
genetic testing and the
no-genetic-testing group;
NS changes in smoking
cessation between the
high-risk and the nonrisk genetic result group
(significance level NR)

Bloss [36],
2011

Adults working
at health and
technology
companies
(n = 3,639;
n = 2,037)

Genetic
testing

None

23 conditions
including breast
and prostate
cancer (NR)

5.6±2.4
months

Nutrition (dietary
fat) and physical
activity

NS changes in nutrition
and/or physical activity
following genetic testing

4

NR

Vernarelli
[51], 2010

Adults with at
least one parent
who developed
Alzheimer
disease
(n = 279;
n = 272)

High-risk
genetic
result

Non-risk
genetic result

Alzheimer
disease (apoE)

6 weeks

Nutrition (dietary
supplement use)
and physical
activity

The high-risk genetic
result group was more
likely to take supplements than the non-risk
genetic result group
(p = 0.0001)

3

No

Hollands [50],
2012

54
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High-risk
genetic
result
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Table 1 (continued)
First author
[Ref.], date

Participants
(n baseline;
n follow-up)

Intervention
group(s)

Comparison
group(s)

Target diseases/
conditions
(genes tested)

Follow-up

Lifestyle habits
assessed

Outcomes (p values);
conclusions

Ranking
of study
design1

COI

Hishida [52],
2010

Adult smokers
(n = 562;
n = 533)

Genetic
testing

No genetic
testing

Lung and
oesophageal cancer
(L-myc)

12 months

Smoking

NS changes in smoking
cessation between the
genetic testing and the
no-genetic-testing group

1

No

Quach [53],
2009

Adults with a
personal and/or
family history of
breast and/or
ovarian cancer
(n = 120; NR)

Genetic
testing

None

Breast and ovarian
cancer (BRCA1/2)

6 months

Nutrition (healthy
diet and vitamin
use) and physical
activity

NS changes in nutrition,
vitamin use, or physical
activity after genetic
testing (significance level
NR)

4

NR

O’Neill [54],
2008

Adult females
(NR; n = 115 at
1 month and
6 months)

High-risk
genetic
result

Uninformative genetic
result

Breast cancer
(BRCA1/2)

1 month
6 months

Nutrition (saturated fat, fruit/
vegetables) and
physical activity

NS differences between
groups in nutrition or
physical activity at
baseline and 1 month or
6 months following
genetic testing

3

NR

Alzheimer disease
(apoE)

12 months

Nutrition (changes in diet, changes
in vitamin/
supplement use)
and physical
activity

The high-risk genetic
result group was more
likely to report a nutrition or physical activity
change than the non-risk
genetic result group (p =
0.003) and the no-genetic-testing group (p =
0.03); most common was
a change in medication/
supplement use (specifically vitamin E)

1

NR

Lung cancer
(GSTM1)

1 week
2 months

Smoking

Fewer cigarettes smoked
(p = 0.009) and greater
quit rates (p = 0.009) at
the 1-week follow-up in
the high-risk genetic
result group than in the
no-genetic-testing group;
NS differences at the
2-month follow-up
between the groups for
cigarettes smoked and
quit rates

1

No

and
Non-risk
genetic result

Chao [55],
2008

Sanderson
[56], 2008

Adult with
parent who
developed
Alzheimer
disease
(n =162;
n = 147)

Genetic
testing

No genetic
testing

and

and

High-risk
genetic
result

Non-risk
genetic result

Adult smokers
(NR; n = 61)

Genetic
testing

No genetic
testing

and

and

High-risk
genetic
result

Non-risk
genetic result

Rees [57],
2007

Adult females
(n = 23)

Genetic
testing

None

Breast cancer
(BRCA1/2)

Varied – up
to 18 months

Nutrition (dietary
changes), physical
activity, and
smoking

Few women reported a
significant impact on
nutrition, physical
activity, and/or smoking
as a result of receiving
genetic testing results
and counselling (significance level not applicable)

Qualitative

NR

Rief [58], 2007

Adults
(n = 294)

Genetic
testing
and
consultation

No genetic
testing –
consultation
only

Obesity (NR)

6 months

Nutrition
(restraint eating)

NS changes to restraint
eating in the genetic
testing group compared
to the no-genetic-testing
groups

1

No

and
No genetic
testing
and no
consultation

Genetic Testing and Lifestyle Behaviour
Change
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Table 1 (continued)
First author
[Ref.], date

Participants
(n baseline;
n follow-up)

Intervention
group(s)

Comparison
group(s)

Target diseases/
conditions
(genes tested)

Follow-up

Lifestyle habits
assessed

Outcomes (p values);
conclusions

Ranking
of study
design1

COI

Carpenter
[59], 2007

Adult smokers
(n = 729;
n = 199)

High-risk
genetic
result

Non-risk
genetic result

Emphysema (AAT)

3 months

Smoking

Those with high-risk
genetic results made
significantly greater quit
attempts than the nonrisk genetic result group
(p = 0.004)

3

NR

Ito [60], 2006

Adult smokers
(n = 697; n =
369 with data
for baseline,
3 and 9 months)

Genetic
testing

No genetic
testing

Lung and
oesophageal cancer
(L-myc)

3 months
9 months

Smoking

NS differences in smoking cessation between
groups at 3 months
(significance level NR)
or 9 months

1

NR

Marteau [61],
2004

Adult probands
and their adult
relatives with
familial hypercholesterolaemia (n = 341;
n = 275)

Genetic
testing

No genetic
testing

Familial
hypercholesterolaemia (NR)

6 months

Nutrition (total
fat and unsaturated fat), physical
activity, and
smoking

NS impact on nutrition,
physical activity, or
smoking with genetic
testing

1

NR

McBride [62],
2002

Adult smokers
(n = 557;
n = 412 at
6 months,
n = 356 at
12 months,
n = 487 with
data from all 3
time points)

Genetic
testing

No genetic
testing

Lung cancer
(GSTM1)

6 months
12 months

Smoking

Greater smoking cessation in the genetic testing
group than in the nogenetic-testing group
(p < 0.006) at 6 months;
NS smoking cessation
rates at 12 months

1

NR

Audrain [24],
1997

Adult smokers
(n = 550;
n = 426)

Genetic
testing

No genetic
testing

Lung cancer
(CYP2D6)

12 months

Smoking

Greater likelihood of quit
attempts in the genetic
testing group than in the
no-genetic-testing group
(p = 0.02); NS change in
30-day cessation between
groups

1

NR

COI, conflict of interest; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid; NS, not statistically significant (p > 0.05 unless otherwise stated); NR, not reported; DTC, direct
to consumer; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid. 1 The rank of the study design is as follows, based on the categories of the NIH Quality Assessment
Tools [29] in combination with consideration of the hierarchy of evidence [63]: 1 = controlled intervention study; 2 = observational cohort/cross-sectional study; 3 = case-control study;
4 = pre-post study with no control group. 2 Note: significance levels for this group of participants are reported in Bloss et al. [36].

cerning, since overall the ratings were “poor” and only 6
of the 26 studies (23%) received a “good” rating. Thus, it
is clear that the studies did not provide high-quality interventions to their participants, which helps to explain
why the majority of studies did not report that genetic
interventions facilitated lifestyle behaviour change.
Are We Considering Validated Behaviour
Change Theory?
Consideration of the TPB and/or one or more of the
theory’s three key components had mode overall ratings
of “poor.” The deductive content analyses of the theoretical underpinnings mentioned in the studies are summarized in online supplementary Table 2. Fifteen studies
(58%) did not make reference to any specific behaviour
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change theory or model within the text. When a theory
was included, it was generally only briefly mentioned and
was not thoroughly incorporated into the study design, or
expanded upon in the discussion. No study specifically
referred to the TPB, suggesting that researchers have yet
to consider this important theory in their study design or
interpretation of findings. Several studies incidentally
considered certain aspects of the TPB in the development
of their scientific methods or within the text, such as the
consideration of behavioural control by assessing one or
more social determinants of health, such as income [64].
Overall, behaviour change theory is not being thoroughly
incorporated into genetic testing behaviour change research.
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Table 2. Summary of quality assessment ratings and impact of genetic testing on lifestyle factor(s) of interest
Ranking
of study
design1

First author
[Ref.], year

1

Roke [43], 2017

Quality assessment rating

Key findings: impact of genetic testing on lifestyle
factor(s) of interest

methods genetic
info

TPB

overall
quality
score

nutrition

Good

Fair

7

Δ
Pa

Fair

Source of
genetic
information

Specific lifestyle
factors with significant
improvement

Other

N/A

Δ

HCP

Improved dietary fat
quality (high-risk genotype
vs. control at 2 weeks and
baseline to 6-month
follow-up in high-risk
genotype group);
decreased intake of highfat, high-sugar foods (in
low-risk genotype vs.
control at 12 months)

Δ

DTC

N/A

PA

smoking

nutrition nutrition,
and PA PA, and
smoking

1

Hietaranta-Luoma
[9], 2015

Fair

Good

Poor

6

1

Marsaux [47], 2015

Fair

Fair

Poor

5

1

Meisel [44], 2015

Poor

Fair

Fair

5

Δ

Δ

DTC

N/A

1

Voils [46], 2015

Fair

Good

Poor

6

Pd
(3 months)
Δ
(6 months)

Δ

HCP

Reduced calories and fat
(MUFA and PUFA)

1

Nielsen [11], 2014

Good

Fair

Poor

6

Δ
(3 months)
Pa
(12 months)

DTC

Reduced sodium intake

1

Hollands [50], 2012

Good

Good

Poor

7

Δ

Other

N/A

1

Hishida [52], 2010

Poor

Poor

Poor

3

Δ

HCP

N/A

HCP

General improvements to
nutrition and PA; vitamin
E supplementation was the
most common change
reported

HCP

Fewer cigarettes smoked
and greater smoking
cessation

HCP

N/A

Δ

Other

N/A

Δ

HCP

N/A

Pd

Other

Greater smoking cessation

HCP

Greater likelihood of quit
attempts

DTC

Greater health behaviour
scores; the most common
changes were “healthier
diet,” “more exercise,” and
“taking vitamins or
supplements”; more often
reported “sufficient fruit
and vegetable intake”

1

Chao [55], 2008

1

Fair

Poor

Poor

4

Sanderson [56], 2008 Poor

Fair

Fair

5

1

Rief [58], 2007

Fair

Good

Poor

6

1

Ito [60], 2006

Poor

Good

Fair

6

1

Marteau [61], 2004

Fair

Fair

Fair

6

(2 weeks)
Pb
(6 months)
Pc
(12 months)

Δ

Pa, e

Δ

Pa
(1 week)
Δ
(2 months)
Δ

Δ

Δ

1

McBride [62], 2002

Poor

Good

Fair

6

1

Audrain [24], 1997

Fair

Fair

Fair

6

Summary2 (n = 15)

Fair

Fair

Poor

5.6

3/8

0/6

3/7

2

Poor

Poor

Poor

3

Pd

Pd

Δ

Egglestone [8], 2013

Genetic Testing and Lifestyle Behaviour
Change

(6 months)
Δ
(12
months)
Pd (quit
attempts)
Δ (30-day
cessation)
1/1
Pd
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Table 2 (continued)
Ranking
of study
design1

First author
[Ref.], year

Quality assessment rating

2

Kaufman [49], 2012

Key findings: impact of genetic testing on lifestyle
factor(s) of interest

methods genetic
info

TPB

overall
quality
score

nutrition

PA

Fair

Poor

Poor

4

Pe

Pe

Summary2 (n = 2)

Fair –
poor

Poor

Poor

3.5

2/2

2/2

3

Fair

Fair

Poor

5

Marsaux [10], 2016

3

Vernarelli [51], 2010

Good

Poor

Poor

5

Pe

3

O’Neill [54], 2008

Good

Poor

Poor

5

Δ

3

Carpenter [59], 2007 Fair

Fair

Poor

5

smoking

nutrition nutrition,
and PA PA, and
smoking

Source of
genetic
information

Specific lifestyle
factors with significant
improvement

DTC +
“Changed their diet” and
optional HCP “started exercising more”
0/1

1/1

Δ

DTC

N/A

Δ

HCP

Greater changes in
supplement use; vitamin E,
vitamin C, botanicals,
multivitamins, vitamin B,
and fish oil/omega were
the most common changes
reported

Δ

HCP

N/A

Pe

DTC +
Greater 24-h quit attempts
optional HCP

Summary2 (n = 4)

Good –
fair

Fair –
poor

Poor

5.0

1/2

0/3

4

Boeldt [45], 2015

Fair

Poor

Fair

5

Δ

Δ

DTC +
N/A
optional HCP

4

Bloss [48], 2013

Fair

Poor

Fair

5

Δ

Δ

DTC +
N/A
optional HCP

4

Bloss [36], 2011

Fair

Poor

Poor

4

Δ

Δ

DTC +
N/A
optional HCP

4

Quach [53], 2009

Fair

Poor

Fair

5

Δ

Δ

HCP

N/A

Fair

Poor

Fair

4.8

0/4

0/4

Good

Poor

Poor

5

Δ

Δ

HCP

N/A

Summary2 (n = 1)

Good

Poor

Poor

5.0

0/1

0/1

Summary of all studies
(n = 26)

FAIR

POOR

POOR 5.2

Summary2
Qualitative

(n = 4)
Rees [57], 2007

1/1

Nutrition: 6/18 (33%)
PA: 2/16 (13%)
Smoking: 4/12 (33%)

Studies with significant beneficial
health behaviour change(s):
7/93 (78%) provided actionable
recommendations
Studies with null findings:
7/14 (50%) provided actionable
recommendations

“Other” sources of genetic information: Roke et al. [43], 2017, used a researcher; McBride et al. [62], 2002, used “trained counsellors”; Ito et al. [60], 2006, used a “trained interviewer”;
Hollands et al. [50], 2009, used a “trained research counsellor.” No studies found a detrimental effect of genetic testing on lifestyle change. P, statistically significant beneficial behaviour
change(s); Δ, no statistically significant behaviour change(s); blank cells, lifestyle factor(s) of interest was/were not assessed; N/A, not applicable; TPB, theory of planned behaviour; PA,
physical activity; HCP, genetic intervention offered through a healthcare provider; DTC, genetic intervention offered direct to consumer; Other, another method was used to deliver the
genetic intervention to the participants; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid. 1 The rank of the study design is as follows, based on the National
Institutes of Health Quality Assessment Tools [29] and the hierarchy of evidence pyramid [63]: 1 = controlled intervention study; 2 = observational cohort/cross-sectional study; 3 =
case-control study; 4 = pre-post study with no control group. 2 n = x indicates the total number of studies included in the summary; modes are reported for each of the three quality
assessment ratings; x/x indicates the number of beneficial behaviour change findings/the total number of studies (note: several studies included multiple analyses such as those with
more than one follow-up time point, and those assessing more than one lifestyle factor of interest); the overall quality score is represented as a mean. 3 Three studies did not provide
information about whether or not actionable recommendations were provided. a High-risk genotype vs. control group. b Baseline to 6-month follow-up in high-risk genotype group.
c Non-risk genotype vs. control group. d Genetic testing group vs. control group. e High-risk genotype group vs. non-risk genotype group.
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Does Genetic Testing Impact Changes in Nutrition,
Physical Activity, and/or Smoking Behaviour?
Overall. Given the heterogeneity of the literature and
complexity of genetics-based behaviour change research,
a cause-and-effect relationship between genetic testing
and health behaviour change cannot be identified. Notably, it appears that it is unlikely that genetic testing has
a “fatalistic” or negative impact on health behaviour
change related to nutrition, physical activity, and smoking, since no study found that genetic testing negatively
impacted the health behaviours of interest to the present
review. Interestingly, 78% of the studies with health-promoting lifestyle behaviour change findings provided
their participants with a genetics-based intervention that
included actionable health behaviour recommendations.
Examples of actionable recommendations provided to
participants for each lifestyle factor included recommendations to reduce sodium intake (nutrition) [11], incorporate exercise into one’s daily routine (physical activity)
[44], and quit smoking (smoking) [24]. Conversely, only
50% of the studies with null findings provided their participants with actionable health behaviour recommendations. Since an overarching cause-and-effect statement
about the impact of genetic testing on behaviour change
cannot be made, a best evidence synthesis is provided
below.
Nutrition. Of the 18 articles that assessed a nutritionrelated outcome, 6 (33%) showed a positive, health-promoting effect of genetic testing on behaviour change at
one or more time points (both short term and long term,
as further outlined in Tables 1 and 2). While this does not
indicate that the majority of studies positively influenced
nutrition, multiple studies of good quality have demonstrated that it is possible to facilitate healthier nutritional
behaviours through the provision of genetic testing [8, 9,
11, 46, 49, 51].
Physical Activity. The provision of genetic testing to
facilitate physical activity behaviour change does not appear to be as promising as behaviour change related to
nutrition. Of the 16 studies that analysed physical activity-related outcomes independently, only 2 (13%) found
positive influences of genetic testing on physical activity
[8, 49], with follow-up periods ranging from 2 to 8 months
in one study [49] and the periods not indicated in the
other study (follow-up varied for each participant) [8].
However, these articles rated poorly in their overall quality assessment, with “poor” to “fair” quality ratings of 3
[8] and 4 [49].
Smoking. Similar to nutrition, 4 (33%) of the 12 genetic intervention studies had a positive influence on

smoking-related behaviours. However, improvements in
smoking-related behaviours were generally only sustained over a short-term period. The overall quality of
these studies was “fair.”
Sleep. It is clear that sleep is an understudied area of
genetic testing and behaviour change research, since our
comprehensive search did not yield a single study that
assessed sleep (sleep quality, hours of sleep, etc.) as a behaviour change outcome.
Pooled Analyses. Two studies completed pooled analyses of changes in more than one lifestyle factor. Chao et
al. [65] did not find significant changes in nutrition or
physical activity on their own, but when pooled together,
there were significantly greater changes to nutrition and
physical activity in the high-risk genetic testing group
than in the non-risk and control groups. Additionally, in
a pooled analysis of changes to nutrition, physical activity, or smoking, Egglestone et al. [8] found significant
changes between the genetic testing group and the control group. However, their results should be interpreted
with caution, as this study was awarded the lowest overall
quality rating of 3 (Table 3).
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Results from Controlled Intervention Trials
While it is important to be comprehensive and consider all studies conducted on the topic of interest regardless of the research methods chosen, controlled interventions should be further highlighted and reviewed separately from other study designs given that this is the
highest possible level of evidence for the original research
included in the present review.
In total, 15 controlled intervention trials have been
conducted over the past two decades. Approximately half
of these studies (n = 7; 47%) found significant changes in
nutrition and/or physical activity or in smoking at 1–3
time points included in the study. Consistent with the
overall analysis, the controlled interventions found that
nutrition was the most promising area of behaviour
change, followed by smoking (short-term only).
The genetic interventions in the controlled intervention trials overall ranked “fair,” demonstrating that in
comparison to the result of the pooled analysis of all study
designs, these studies provided their participants with
higher-quality genetic interventions. This may help explain why 47% of the controlled intervention studies
found significant changes in lifestyle habits resulting
from the genetic intervention, compared to 36% of the
studies using other study designs. The overall ranking of
these studies was “fair,” with a mean rating of 5.6 out of
the highest possible score of 9. Risk of bias overall was
59

Table 3. Frequencies of genes tested in genetic interventions and
their reported associated health outcomes

Gene

Frequency

Health outcomes reported to be
associated with the gene

AAT
ACE
apoE

1
1
3

BRCA1

3

BRCA2

3

CYP1A2
CYP2D6
FADS1
FTO
GSMT1

1
1
1
3
3

GSTT1
KCNJ11
L-myc

1
1
2

NOD2
PPARγ
TAS1R2
TCF7L2

1
1
1
1

Emphysema
Salt sensitivity
Alzheimer disease
Cardiovascular disease
Breast cancer
Ovarian cancer
Breast cancer
Ovarian cancer
Caffeine metabolism
Lung cancer
Omega-3 metabolism
Overweight/obesity
Lung cancer
Vitamin C utilization
Vitamin C utilization
Type 2 diabetes
Lung cancer
Oesophageal cancer
Crohn disease
Type 2 diabetes
Sweet taste preference
Type 2 diabetes

Of the studies that reported the specific genes tested in the
genetic intervention, single nucleotide polymorphisms in 16
unique genes were tested, with apoE, BRCA1/2, FTO, and GSTM1
having the highest frequencies of use in the genetic intervention.

“fair” and consideration of the TPB was rated to be “poor,”
which is consistent with the results of the analysis of all
study designs combined.
Discussion

Given that decoding the entire human genome was the
primary focus of genetic research until 2003 [1], it is not
surprising to find that the majority of studies included in
the present review were published after this time, with
only 2 studies published before 2003. Since then, much
greater focus has been placed on genetic testing behaviour change research pertaining to nutrition, physical activity, and smoking. However, several studies included in
the present review (46%) did not include a COI statement. Future research should ensure the inclusion of a
COI statement given this concerning finding and given
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the increased emphasis in academia on the importance of
considering COI in genetic testing and other research.
Improving one or more of the four lifestyle behaviours
of interest to this review has been shown to have a beneficial effect on chronic disease management and general
health and well-being [20–23]. The present review indicated that improvements to smoking habits were promising in the short-term. This finding was consistent with
that of a previously published systematic review of the
impact of genetic notification on smoking cessation [66].
While nutrition, physical activity, and smoking habits
have been researched in multiple genetic intervention
studies, sleep remains an understudied area of genetics
and behaviour change. This is notable considering the
substantial impact that sleep has on overall health and
well-being. Current systematic reviews demonstrate a
significant impact of sleep on cognition and emotion
[67], glycaemic control [22], and overweight or obesity
[23], to name a few. To our knowledge, little is known
about the ability of sleep to modify gene-associated health
risks. Thus, future research should seek to first determine
gene-sleep interactions that may influence health outcomes using methodologies similar to those of nutrigenomics research, as opposed to a genome-wide association study approach. Upon determining ways in which
sleep may mitigate genetics-associated health risks, future
research should then seek to determine if genetic testing
helps to motivate healthy sleep-related behaviours.
The considerable heterogeneity in studies (Tables 1, 2)
can be explained by a number of factors. Notably, the
variation of statistical analyses between groups (i.e., genetic testing groups vs. control groups or high-risk genetic result groups vs. non-risk genetic result groups)
would have impacted the findings and subsequent conclusions drawn. Consideration of theories in general to
inform the study design was poor, and consideration of
the TPB was absent, which further helps to explain the
heterogeneity of findings, since several possible confounding factors were missed. Additionally, only 3 studies [9, 11, 43] focused on nutrient metabolism. Therefore,
a future focus is needed on genetic interventions related
to nutrient metabolism and the subsequent disease risk
through genetic testing of modifier genes (genetic risks
that can be mitigated through specific lifestyle changes),
rather than genetics-based disease risk estimates where
there may be no known lifestyle modifications that can
alter the genetic risk. It is possible that nutrition was the
most promising lifestyle factor for promoting health behaviour change given that genetic testing of modifier
genes typically leads to the provision of actionable recomHorne/Madill/O’Connor/Shelley/Gilliland

mendations (e.g., the recommendation to reduce sodium
intake [11]).
It is important to note that our risk-of-bias results are
consistent with the previously published literature [3, 6],
providing validation for the NIH quality assessment process completed in the current review. Effect sizes were not
included in this review due to heterogeneity of the genetic interventions and study designs of the included articles
that would have introduced potential flaws in effect size
calculations and any conclusions drawn from such calculations. For randomized controlled trials, effect sizes have
recently been presented elsewhere [3], although these
should be interpreted with caution due to the significant
heterogeneity of treatments (genetic interventions), measurements of outcomes, and populations studied. To our
knowledge, we have developed and utilized the first quality assessment tool for evaluating and rating genetic
interventions. Future research should seek to utilize this
novel tool and significant contribution to the literature to
assess the quality of genetic interventions in both primary research and systematic reviews. Furthermore, the
components of this tool can be used in future genetic testing behaviour change study design to improve the quality
of genetic interventions provided to participants (online
suppl. Table 1). Although the genetic intervention quality
assessment was based on previously published robust research and critical commentaries [11, 31–38], assessing
the quality of evidence supporting the genetic tests provided to participants was beyond the scope of the present
review. This is an important area of future research and
is a notable ethical concern of genetic testing.
This review provides the most comprehensive analysis
of genetic testing behaviour change research completed
to date. However, some limitations to the present review
exist. While this review summarized whether the genetic
information was delivered direct to consumer or through
a healthcare provider (Table 3), the practice of each provider is inevitably distinct. Some may incorporate behaviour change theory into their practice in order to maximally promote health behaviour change, while others
may simply provide an explanation of the genetic results.
This limitation further highlights the complexity of genetic testing behaviour change research. Additionally, the
TPB was chosen as the key theory of interest given that it
is one of the most widely accepted and validated theories
of behaviour change, with over 4,500 publications referencing this theory and several meta-analyses finding that
the key components of the TPB can be used to predict
behavioural intentions with mean multiple correlations
ranging from 0.59 to 0.67 [15, 68–73]. However, a num-

ber of other theories have been validated and are frequently used in behaviour change research, such as the
transtheoretical model [74].
By improving upon genetic testing behaviour change
studies, we anticipate the development of an algorithm
that can be used to inform effective genetic testing behaviour change interventions for individuals who might
benefit from this more personalized approach to healthcare. Indeed the limitations of genetic testing and the
possible risk of harm [75] should be considered prior to
an individual’s decision to undergo genetic testing, especially in situations where one may learn about their risk
of developing a disease, where actionable strategies for
mitigating the risk are currently unknown [75]. Given
that behaviour change is complex and multifactorial and
studies have yet to robustly incorporate validated theory
and high-quality genetic interventions into their methods, we cannot conclude with a broad statement about
the impact of genetic testing on behaviour change. However, it is clear that it is possible to facilitate behaviour
change through the provision of high-quality genetic
interventions. Incorporating behaviour change theory
into future research is an important consideration to enhance our knowledge in this field. Specific recommendations for study design have recently been published elsewhere [18]. An interdisciplinary research team with expertise in genomics as well as behaviour change may be
the optimal approach given the complexities of this field
of study. Considerable future research is needed in this
promising and exciting area of lifestyle behaviour change
research.
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Conclusion

The use of validated theory to inform a robust study
design [18] and the provision of actionable, high-quality,
genetics-based information and advice is recommended
to test a behaviour change hypothesis in genetics research.
Rather than using the traditional systematic review process of assessing solely risk of bias, we have demonstrated
that factors beyond risk of bias influence research outcomes related to genetic testing and behaviour change. As
more robust literature continues to be published, allowing for the determination of key components of genetic
interventions that best facilitate behaviour change, lifestyle genomics behaviour change research has the potential to make a substantial impact on global health and
well-being through the facilitation of personalized,
health-promoting lifestyle behaviour change.
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